Portugal – Medicinal products for the blood, blood-forming organs and the cardiovascular system – 2023/0491 - NATALIZUMAB [20 MG/ML; 15 ML; FRS]
Tender Description
NATALIZUMAB [20 MG/ML; 15 ML; FRS]
Iftaħ Għarfien Sħiħ dwar it-Tender
Id-dettalji u l-analiżi AI kollha huma disponibbli fuq tend.ee. Oħloq kont bla ħlas.
Bla ħlas biex tibda. Ebda karta tal-kreditu meħtieġa.
